Details for 2018817811

Up to date per 02.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE FORMULIERUNGEN VON N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMID UND SALZEN DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018817811

EP Publication Number

3638241

E-Number

1493989

Language

PCT Number

US18037744

Publication Date

22.04.2020 A

25.05.2022 B1

Registration Date

25.05.2022

AT Publication Date

15.06.2022

Application Date

15.06.2018

Registration Number

Priorities

16.06.2017

201762521007 P

IPC

A61K 31/506 20060101AFI20200901BHEP

Maximum Duration of Protection

15.06.2038

Owner

Beta Pharma, Inc.1000 N. West Street Suite 1200 Wilmington, DE 19801US

Representative

No representatives present

Inventor

GRECO, Michael, Nicholas1634 Clearbrook Road Lansdale PA 19446US

COSTANZO, Michael, John14 Breckenridge Drive Warminster PA 18974US

GREEN, Michael, Alan1184 Dewalt Drive Easton PA 18040US

PENG, Jirong11019 North Kensington Dr. Mequon WI 53097US

WILDE, Victoria, Lynn50 Pine Street Apt. 41 Montclair NJ 07042US

ZHANG, Don9 Kensington Court Princeton NJ 08540US